Single-nucleus multiomic atlas of frontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms.
Paul M McKeeverAiden M SababiRaghav SharmaNicholas KhuuZhiyu XuShu Yi ShenShangxi XiaoPhilip McGoldrickElias OroujiTroy KetelaChristine SatoDanielle MorenoNaomi VisanjiGabor G KovacsJulia KeithLorne ZinmanEkaterina A RogaevaHani GoodarziGary D BaiderJanice RobertsonPublished in: bioRxiv : the preprint server for biology (2023)
The understanding of how different cell types contribute to amyotrophic lateral sclerosis (ALS) pathogenesis is limited. Here we generated a single-nucleus transcriptomic and epigenomic atlas of the frontal cortex of ALS cases with C9orf72 (C9) hexanucleotide repeat expansions and sporadic ALS (sALS). Our findings reveal shared pathways in C9-ALS and sALS, characterized by synaptic dysfunction in excitatory neurons and a disease-associated state in microglia. The disease subtypes diverge with loss of astrocyte homeostasis in C9-ALS, and a more substantial disturbance of inhibitory neurons in sALS. Leveraging high depth 3'-end sequencing, we found a widespread switch towards distal polyadenylation (PA) site usage across ALS subtypes relative to controls. To explore this differential alternative PA (APA), we developed APA-Net, a deep neural network model that uses transcript sequence and expression levels of RNA-binding proteins (RBPs) to predict cell-type specific APA usage and RBP interactions likely to regulate APA across disease subtypes.
Keyphrases
- amyotrophic lateral sclerosis
- single cell
- rna seq
- neural network
- deep learning
- spinal cord
- poor prognosis
- working memory
- machine learning
- healthcare
- minimally invasive
- inflammatory response
- cell therapy
- spinal cord injury
- optical coherence tomography
- genome wide
- long non coding rna
- gene expression
- artificial intelligence
- mesenchymal stem cells
- binding protein
- bone marrow
- early onset
- health insurance
- nucleic acid